Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting

PURPOSE: To establish a baseline for care and overall survival (OS) based upon contemporary first-line treatments prescribed in the era before the introduction of immune checkpoint inhibitors, for people with metastatic non-small cell lung cancer (NSCLC) without common actionable mutations. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Abernethy, Amy P., Arunachalam, Ashwini, Burke, Thomas, McKay, Caroline, Cao, Xiting, Sorg, Rachael, Carbone, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482433/
https://www.ncbi.nlm.nih.gov/pubmed/28644837
http://dx.doi.org/10.1371/journal.pone.0178420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482433/
https://www.ncbi.nlm.nih.gov/pubmed/28644837
http://dx.doi.org/10.1371/journal.pone.0178420

Ejemplares similares